Skip to main content

Table 5 Treatment-related adverse events

From: Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

Symptom

CTCAE v4.0

Any grade

Grade 1

Grade 2

No.

%

No.

%

No.

%

Dry mouth

69

49.3

66

47.1

3

2.1

Hiccups

47

33.6

42

30.0

5

3.6

Constipation

97

69.3

69

49.3

28

20.0

Dizziness

41

29.3

41

29.3

0

0.0

Insomnia

62

44.3

58

41.4

4

2.9

Somnolence

96

68.6

92

65.7

4

2.9

  1. CTCAE v4.0 Common Terminology Criteria for Adverse Events version 4.0.